Benzinga | May 6, 2021 07:47AM EDT

Intercept Pharmaceuticals Q1 EPS $(1.22) Beats $(1.44) Estimate, Sales $81.66M Beat $81.20M Estimate

Intercept Pharmaceuticals (NASDAQ:ICPT) reported quarterly losses of $(1.22) per share which beat the analyst consensus estimate of $(1.44) by 15.28 percent. This is a 57.34 percent increase over losses of $(2.86) per share from the same period last year. The company reported quarterly sales of $81.66 million which beat the analyst consensus estimate of $81.20 million by 0.57 percent. This is a 12.40 percent increase over sales of $72.65 million the same period last year.